The year's new drugs & biologics 2014: Part I

Drugs of Today

Volumn 51, Issue 1, 2015, Pages 37-87

  Craul, A I ^a   Cruces, E ^a   Stringer, M ^a  

^a THOMSON REUTERS   (United Kingdom)

Author keywords

First in class drugs; Line extensions; New drug approvals; New drug launches

Indexed keywords

AGENTS ACTING ON THE EYE; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DERMATOLOGICAL AGENT; DIAGNOSTIC AGENT; GASTROINTESTINAL AGENT; HEMATOLOGIC AGENT; HORMONE; IMMUNOMODULATING AGENT; NEUROLEPTIC AGENT; NEW DRUG; ORPHAN DRUG; RESPIRATORY TRACT AGENT; URINARY TRACT AGENT; DRUG;

ARTICLE; BACTERIAL INFECTION; DRUG APPROVAL; DRUG INDUSTRY; DRUG MARKETING; EUROPEAN UNION; HEPATITIS C; HUMAN; JAPAN; MULTIDRUG RESISTANCE; NONHUMAN; UNITED STATES; CLASSIFICATION; DRUG DEVELOPMENT; TIME FACTOR;

BIOLOGICAL PRODUCTS; DRUG APPROVAL; DRUG DISCOVERY; HUMANS; PHARMACEUTICAL PREPARATIONS; TIME FACTORS;

EID: 84922357399     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2015.51.1.2279964     Document Type: Article

References (9)

1. Morgenthaler, T. I., Lee-Chiong, T., Alessi, C. et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep 2007, 30(11):1445-59.
2. Yamada, T., Saito, H., Fujieda, S. Present state of Japanese cedar pollinosis: The national affliction. J Allergy Clin Immunol 2014, 133(3):632-9.
3. Lozano, R., Naghavi, M., Foreman, K. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2095-128.
4. Coyne, K. S., Lo Casale, R. J., Datto, C. J., Sexton, C. C., Yeomans, K., Tack, J. Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: Descriptive analysis of baseline patient-reported outcomes and retrospective chart review. Clinicoecon Outcomes Res 2014, 6:269-81.
5. IDF Diabetes Atlas, 6th edition (International Diabetes Federation, 2013). http://www.idf.org/sites/default/files/EN-6E-Atlas-Full-0.pdf.
6. Antimicrobial resistance: Tackling a crisis for the health and wealth of nations. The review on antimicrobial resistance - chaired by Jim O'Neill. December 2014. http://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations-1.pdf.
7. Hepatitis C. Fact sheet NQ 164 (World Health Organization, updated April 2014). http://www.who.int/mediacentre/factsheets/fsl64/en/.
8. Clobocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 (International Agency for Research on Cancer). http://globocan. iarc.fr/Default.aspx.
9. Polycythemia vera facts (Leukemia & Lymphoma Society, revised June 2012). http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/mpd/pdf/polycythemiavera.pdf.